Molnupiravir, the second oral antiviral medication approved for the treatment of COVID-19, has been approved in Singapore

Molnupravir, an antiviral agent, will be the second oral pharmaceutical licenced in Singapore for the treatment of adult COVID-19 patients, the Health Sciences Authority (HSA) said on Tuesday (Apr 19).

On Tuesday, the HSA granted interim approval for MSD's Lagevrio under the Pandemic Special Access Route (PSAR), in collaboration with its Medicines Advisory Committee.

Molnupiravir, marketed as Lagevrio, is the second ora....